Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H12N2O3 |
Molecular Weight | 232.2353 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
InChI
InChIKey=DDBREPKUVSBGFI-UHFFFAOYSA-N
InChI=1S/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17)
Molecular Formula | C12H12N2O3 |
Molecular Weight | 232.2353 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:27:44 UTC 2023
by
admin
on
Fri Dec 15 16:27:44 UTC 2023
|
Record UNII |
YQE403BP4D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QN03AA02
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
||
|
CFR |
21 CFR 1308.22
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
||
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
||
|
WHO-ATC |
N03AA02
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
05
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
||
|
EPA PESTICIDE CODE |
600122
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
||
|
FDA ORPHAN DRUG |
725519
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
||
|
FDA ORPHAN DRUG |
703819
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
||
|
FDA ORPHAN DRUG |
601717
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
||
|
LIVERTOX |
NBK548269
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
||
|
NCI_THESAURUS |
C67084
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
||
|
IARC | Phenobarbital | ||
|
DEA NO. |
2285
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
||
|
CFR |
21 CFR 862.3660
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2804
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
2134
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
C739
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
PHENOBARBITAL
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
1524001
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
200-007-0
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
PHENOBARBITAL
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | Description: Colourless crystals or a white, crystalline powder; odourless. Solubility: Soluble in about 1100 parts of water, in about 10 parts of ethanol (~750 g/l) TS and in about 15 parts of ether R. Category: Hypnotic; sedative; anticonvulsant. Storage: Phenobarbital should be kept in a well-closed container. Additional information: Phenobarbital may exhibit polymorphism. Definition: Phenobarbital contains not less than 98.0% and not more than 101.0% of C12H12N2O3, calculated with reference tothe dried substance. | ||
|
100000090330
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
8069
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
YQE403BP4D
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
Phenobarbital
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
DTXSID5021122
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
m8622
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | Merck Index | ||
|
28918
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
9848
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
D010634
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
3157
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
CHEMBL40
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
YQE403BP4D
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
DB01174
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
4763
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
SUB09770MIG
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
128143
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
50-06-6
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | |||
|
8134
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY | RxNorm | ||
|
414
Created by
admin on Fri Dec 15 16:27:44 UTC 2023 , Edited by admin on Fri Dec 15 16:27:44 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> INDUCER | |||
|
METABOLIC ENZYME -> INDUCER | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
METABOLIC ENZYME -> INDUCER | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> INDUCER | |||
|
LABELED -> NON-LABELED |
|
||
|
BINDER->LIGAND |
|
||
|
METABOLIC ENZYME -> INDUCER | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
Metabolite to parent drug ratio in non-uraemic human plasma.
METABOLITE TO PARENT DRUG RATIO
PLASMA; URINE
|
||
|
PARENT -> METABOLITE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
Elimination PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC |
|
||